Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07282275 · ClinicalTrials.gov registry record · NA

How Does Continued Use of Green Light Therapy Impact Outcomes?

A NA study of Body Composition, sponsored by Efforia.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT07282275 is a NA study of Body Composition that is actively recruiting participants, run by Efforia. The registered enrollment target is 100 participants, below the 111-participant average among 20 other Body Composition trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07282275, a NA study of Body Composition, is actively recruiting participants, sponsored by Efforia.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Already using Green Light Therapy? Explore how continued use with twice-weekly 20-minute sessions may continue to support positive changes in body composition. Discover whether this non-invasive wellness approach gets better over time to help support energy, balance, and renewal.

Conditions Studied

Interventions

  • DEVICE EmeraldLED

Study Locations (1)

New York

  • Efforia - New York

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-10-21
Est. Completion 2026-10-21
Phase NA

Sponsor

Efforia

19 total trials

What the Registry Record Tells You About NCT07282275

The ClinicalTrials.gov registry entry for NCT07282275 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 111-participant average among 20 other Body Composition trials with a reported enrollment target (10% lower). The listed sponsor is Efforia, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Body Composition appearing as the primary indexed condition, and to 1 intervention - of which EmeraldLED is the first listed.

NCT07282275 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07282275 about?

NCT07282275 is a clinical study titled "How Does Continued Use of Green Light Therapy Impact Outcomes?". Already using Green Light Therapy? Explore how continued use with twice-weekly 20-minute sessions may continue to support positive changes in body composition. Discover whether this non-invasive wellness approach gets better over time to help support energy, balance, and renewal.

What is the current status of trial NCT07282275?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-10-21. Estimated completion is 2026-10-21.

What conditions does trial NCT07282275 study?

This clinical trial studies the following conditions: Body Composition.

What interventions are being tested in trial NCT07282275?

The interventions under investigation include: EmeraldLED (DEVICE).

Who is sponsoring clinical trial NCT07282275?

This trial is sponsored by Efforia, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07282275 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Body Composition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.